Mark A Merkley1, Tristan C Bice2, Alex Grier3, Alexis M Strohl1, Li-Xing Man1, Steven R Gill3,4. 1. Department of Otolaryngology Head and Neck Surgery, University of Rochester Medical Center, Rochester, NY. 2. School of Medicine and Dentistry, University of Rochester, Rochester, NY. 3. Genomics Research Center, University of Rochester Medical Center, Rochester, NY. 4. Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY.
Abstract
BACKGROUND: Current treatment of acute exacerbations of chronic rhinosinusitis (CRS) is driven by identification of predominant bacteria using culture-based methods and determination of antibiotic sensitivities. The objective of this study was to evaluate the response of the sinonasal microbiome to antibiotic therapy in the setting of an acute exacerbation of CRS. METHODS: Aspirate and swab samples for culture and DNA analysis were collected bilaterally from 8 CRS patients presenting with acute exacerbations. Patients were started on a 2-week course of a culture-directed antibiotic after sensitivities were determined. Repeat samples were taken immediately on the completion of treatment. DNA was extracted from each sample, amplified using bacterial 16S primers and sequenced. Bacterial abundance was determined by quantitative polymerase chain reaction (qPCR). Diversity metrics of the microbiota between pretreatment and posttreatment samples were calculated. RESULTS: There was significantly more bacterial DNA present in the pretreatment group than in the posttreatment group. An increase in α-diversity was found in the posttreatment group relative to the pretreatment group (p < 0.05 in each comparison) with swab sampling, but not by aspirate sampling. The predominant organism identified by 16S sequencing correlated with the culture-identified bacteria genus in each patient. CONCLUSION: Significant differences exist in the diversity of bacteria populations during acute exacerbations of CRS and after antimicrobial treatment. After therapy, the increase in diversity is accompanied by a decrease in the total of abundance of the bacterial population.
RCT Entities:
BACKGROUND: Current treatment of acute exacerbations of chronic rhinosinusitis (CRS) is driven by identification of predominant bacteria using culture-based methods and determination of antibiotic sensitivities. The objective of this study was to evaluate the response of the sinonasal microbiome to antibiotic therapy in the setting of an acute exacerbation of CRS. METHODS: Aspirate and swab samples for culture and DNA analysis were collected bilaterally from 8 CRSpatients presenting with acute exacerbations. Patients were started on a 2-week course of a culture-directed antibiotic after sensitivities were determined. Repeat samples were taken immediately on the completion of treatment. DNA was extracted from each sample, amplified using bacterial 16S primers and sequenced. Bacterial abundance was determined by quantitative polymerase chain reaction (qPCR). Diversity metrics of the microbiota between pretreatment and posttreatment samples were calculated. RESULTS: There was significantly more bacterial DNA present in the pretreatment group than in the posttreatment group. An increase in α-diversity was found in the posttreatment group relative to the pretreatment group (p < 0.05 in each comparison) with swab sampling, but not by aspirate sampling. The predominant organism identified by 16S sequencing correlated with the culture-identified bacteria genus in each patient. CONCLUSION: Significant differences exist in the diversity of bacteria populations during acute exacerbations of CRS and after antimicrobial treatment. After therapy, the increase in diversity is accompanied by a decrease in the total of abundance of the bacterial population.
Authors: Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas Journal: Clin Microbiol Rev Date: 2017-01 Impact factor: 26.132
Authors: J R Kuiper; A G Hirsch; K Bandeen-Roche; A S Sundaresan; B K Tan; R P Schleimer; R C Kern; W F Stewart; B S Schwartz Journal: Allergy Date: 2018-02-07 Impact factor: 13.146
Authors: J Xiao; A Grier; R C Faustoferri; S Alzoubi; A L Gill; C Feng; Y Liu; R G Quivey; D T Kopycka-Kedzierawski; H Koo; S R Gill Journal: J Dent Res Date: 2018-07-26 Impact factor: 6.116
Authors: Ji Heui Kim; Sung Hee Kim; Ji Youn Lim; Doyeon Kim; In Seong Jeong; Dong Kyu Lee; Yong Ju Jang Journal: Exp Mol Med Date: 2020-06-29 Impact factor: 8.718
Authors: Mary-Claire Roghmann; Alison D Lydecker; Michelle Shardell; Robert T DeBoy; J Kristie Johnson; LiCheng Zhao; Lauren L Hittle; Emmanuel F Mongodin Journal: PLoS One Date: 2021-06-08 Impact factor: 3.240